✦ LIBER ✦

Southwest Oncology Group 0408: Phase II Trial of Neoadjuvant Capecitabine/Oxaliplatin/Bevacizumab for Resectable Colorectal Metastases in the Liver

✍ Scribed by Eddie K. Abdalla; Cathy Eng; Alice Madary; Jean-Nicolas Vauthey

Book ID: 119935038
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 451 KB
Volume: 5
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2006.n.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6076 BOXER: A multicentre phase II trial

6076 BOXER: A multicentre phase II trial of capecitabine and oxaliplatin plus bevacizumab as neoadjuvant treatment for patients with liver-only metastases from colorectal cancer unsuitable for upfront resection

✍ Wong, R.; Saffery, C.; Barbachano, Y.; Chau, I.; Valle, J.; Hickish, T.; Mudan, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Randomized multicenter Phase II trial of

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

✍ Emilio Bajetta; Maria Di Bartolomeo; Luigi Mariani; Antonio Cassata; Salvatore A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## BACKGROUND The aim of the current randomized Phase II study was to investigate the efficacy and safety of capecitabine combined with irinotecan as first‐line treatment in metastatic colorectal carcinoma (CRC). ## METHODS A total of 140 patients received capecitabine at a dose of 1